BlackRock Inc. increased its holdings in shares of Fulgent Genetics by 3.4% during the first quarter.

Source: https://www.americanbankingnews.com/2023/11/12/fulgent-genetics-inc-nasdaqflgt-shares-sold-by-truist-financial-corp.html

Given the existing customer network at Fulgent Genetics and Inform Diagnostics, Fulgent Genetics can leverage the existing sales force to cross sell testing services and expand its overall customer base.

Source: https://seekingalpha.com/article/4580000-fulgent-genetics-stock-i-prefer-to-hold-for-now?source=feed_all_articles

Given the existing customer network at Fulgent Genetics and Inform Diagnostics, Fulgent Genetics can leverage the existing sales force to cross sell testing services and expand its overall customer base.

Source: https://seekingalpha.com/article/4580000-fulgent-genetics-stock-i-prefer-to-hold-for-now?source=feed_all_articles

The company issued revenue guidance of -. Fulgent Genetics also updated its FY23 guidance to ($0.95) EPS.

Source: https://www.dailypolitical.com/2023/08/05/fulgent-genetics-nasdaqflgt-updates-fy-2023-earnings-guidance.html